Phillip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 60,000 shares at $124.30 ($7.5M) on 2020-11-25, disclosed to the SEC on 2020-11-30.
Open-market sale of $7.5M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.30 | 11,523 | $1.4M | 19.1% |
| 2 | $124.30 | 11,523 | $1.4M | 19.1% |
| 3 | $125.05 | 15,715 | $2.0M | 26.2% |
| 4 | $125.05 | 15,715 | $2.0M | 26.2% |
| 5 | $126.16 | 2,117 | $267K | 3.6% |
| 6 | $126.16 | 2,117 |
| $267K |
| 3.6% |
| 7 | $127.44 | 645 | $82K | 1.1% |
| 8 | $127.44 | 645 | $82K | 1.1% |
| Total | $124.89 avg | 60,000 | $7.5M | 100% |
| Filing → |
| ALNY | SELL | 2022-08-17 | $12.8M | — | Filing → |
| ALNY | SELL | 2022-02-11 | $4.5M | — | Filing → |
| ALNY | SELL | 2020-02-13 | $3.9M | — | Filing → |